Cemtrex Rises on New Repurchase Authorization

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cemtrex Rises on New Repurchase Authorization

© Thinkstock

Shares of Cemtrex Inc. (NASDAQ: CETX) saw a handy gain in Wednesday’s session immediately following the announcement of a new share repurchase plan. The company announced that its board of directors approved a new repurchase authorization for up to a million of its outstanding shares over the next 12 months.

Although this does not seem like much, the company only has a market cap of roughly $31 million, and the average daily volume of shares is about 250,000.

Under this new stock repurchase authorization, the company may repurchase shares in open-market purchases in line with all applicable securities laws and regulations. The extent to which Cemtrex repurchases its shares, and the timing of such repurchases, is dependent on a few different factors, including market conditions, regulatory requirements and other corporate considerations, as determined by Cemtrex’s management team. The repurchase program may be suspended or discontinued at any time.

[nativounit]

Saagar Govil, chairman and chief executive of Cemtrex, commented:

This share repurchase plan, the first in the Company’s operating history, demonstrates our commitment to providing value to our shareholders and reflects our confidence in our business and growth prospects, as we continue to expand both organically and through strategic transactions such as the recent Periscope acquisition.

So far in 2016, Cemtrex has outperformed the broad markets, with the stock up over 30%.

The stock was trading up nearly 17% at $3.59 on Wednesday afternoon, with a consensus analyst price target of $3.80 and a post-IPO trading range of $1.56 to $5.19.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618